Study of CM313 in Subject With IgA Nephropathy
Clinical trial NCT06830395 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06830395
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-03-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.